Back to School: How biopharma can reboot drug development. Access exclusive analysis here

LABI (formerly Basulin): Completed Phase I trial

Flamel Technologies SA (FLMLY), Lyon, France
Product:

Read the full 78 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE